| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S001250050249 |
| P698 | PubMed publication ID | 7744225 |
| P2093 | author name string | S Kato | |
| Y Seino | |||
| H Ishida | |||
| K Tsuda | |||
| T Miura | |||
| K Masuda | |||
| H Horikoshi | |||
| Y Okamoto | |||
| Y Tsuura | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A | Q28131712 | ||
| Sulfonylurea signal transduction | Q33239501 | ||
| Structure and function of mammalian facilitative sugar transporters. | Q34061456 | ||
| The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro | Q34344869 | ||
| Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells | Q36427862 | ||
| Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats | Q38346193 | ||
| Glucose as regulator of glucose transport activity and glucose-transporter mRNA in hamster beta-cell line | Q41625970 | ||
| A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact | Q41717895 | ||
| In vitro studies on the action of CS-045, a new antidiabetic agent | Q42478353 | ||
| A pilot clinical trial of a new oral hypoglycemic agent, CS-045, in patients with non-insulin dependent diabetes mellitus. | Q46031824 | ||
| Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects | Q46090838 | ||
| Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. | Q51608769 | ||
| Monolayer cultures of adult pancreatic islet cells on osmotically disrupted fibroblasts. | Q52504240 | ||
| Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose | Q67530632 | ||
| Role of cytosolic Ca2+ in impaired sensitivity to glucose of rat pancreatic islets exposed to high glucose in vitro | Q67589791 | ||
| Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice | Q68047811 | ||
| Impaired glucose sensitivity of ATP-sensitive K+ channels in pancreatic beta-cells in streptozotocin-induced NIDDM rats | Q68169138 | ||
| Increased liver glucose-transporter protein and mRNA in streptozocin-induced diabetic rats | Q68499363 | ||
| The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells | Q69010313 | ||
| An improved method for isolation of mouse pancreatic islets | Q70103136 | ||
| Characteristic features of insulin secretion in the streptozotocin-induced NIDDM rat model | Q70222841 | ||
| The structure-hemolysis relationship of oleanolic acid derivatives and inhibition of the saponin-induced hemolysis with sapogenins | Q71067996 | ||
| Suppressive effects of polygonati rhizoma on hepatic glucose output, GLUT2 mRNA expression and its protein content in rat liver | Q72782591 | ||
| Disopyramide blocks pancreatic ATP-sensitive K+ channels and enhances insulin release | Q72917343 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 24-30 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide | |
| P478 | volume | 38 |
| Q42523561 | Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes |
| Q37141727 | Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus |
| Q42512444 | Effects of high-dose troglitaz one on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits |
| Q35047497 | Expression and functional activity of PPARgamma in pancreatic beta cells |
| Q37577126 | In vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion |
| Q34962291 | Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions |
| Q46050871 | Insulin-dependent actions of pioglitazone in newly diagnosed, drug naïve patients with type 2 diabetes |
| Q37577162 | Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes |
| Q36068458 | Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity. |
| Q35989381 | Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus |
| Q51556166 | Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus. |
| Q39862439 | Serine-385 phosphorylation of inwardly rectifying K+ channel subunit (Kir6.2) by AMP-dependent protein kinase plays a key role in rosiglitazone-induced closure of the K(ATP) channel and insulin secretion in rats. |
| Q39748018 | Suppression effects of AICAR on insulin secretion involved in peroxisome proliferator-activated receptor gamma changes in INS-1 cells. |
| Q37138791 | The effects of Leptin and Adiponectin on Pdx1, Foxm1, and PPARγ Transcription in Rat Islets of Langerhans |
| Q33607634 | Thiazolidinediones: a new class of antidiabetic drugs |
| Q41521276 | Troglitazone |
Search more.